Literature DB >> 20648030

Regulatory challenges, reimbursement, and risk-benefit assessment.

A Breckenridge.   

Abstract

Mesh：

Year:  2010        PMID： 20648030     DOI： 10.1038/clpt.2010.76

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  Good decision making requires good communication.

Authors:  Baruch Fischhoff
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

Review 2.  Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.

Authors:  Dominic Way; Hortense Blazsin; Ragnar Löfstedt; Frederic Bouder
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

3.  A practical approach to communicating benefit-risk decisions of medicines to stakeholders.

Authors:  James Leong; Stuart Walker; Sam Salek
Journal:  Front Pharmacol       Date:  2015-06-11       Impact factor: 5.810

4.  Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documents.

Authors:  James Leong Wai Yeen; Sam Salek; Stuart Walker
Journal:  Front Pharmacol       Date:  2014-12-04       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.